Susie Joron, Transplant and Cellular Therapy Administrative Director at HCA Healthcare, shared HCA Florida North Florida Hospital’s post on LinkedIn, adding:
“Reposting this important message from Dr. Navneet Majhail, Head of Transplant and Cell Therapy Services at Sarah Cannon.
His leadership at the Sarah Cannon network level is instrumental in helping programs like ours succeed by advancing a shared vision for high-quality, patient-centered transplant and cellular therapy care.
At HCA Florida North Florida Hospital, we are also very fortunate to have strong local medical leadership guiding the development of our Transplant and Cellular Therapy program. A special recognition to our dedicated medical team, including Dr. Zeina Al-Mansour, Jack Hsu and Hugo Akabane, whose expertise, commitment, and collaboration are helping us build a program grounded in high quality cellular therapy services.
Grateful to be part of this work and to contribute to the growth of transplant and cellular therapy services for our patients and community.”
Quoting HCA Florida North Florida Hospital’s post:
“Approximately 192,000 people will be diagnosed with blood cancer in the U.S. this year, according to the American Cancer Society.
Dr. Navneet Majhail explains common types of blood cancer, symptoms to watch for and when to talk with a doctor. Dr. Majhail is a hematologist and physician in chief of blood cancers for HCA Healthcare Sarah Cannon Cancer Network.
As part of our broader network of care, the HCA Healthcare Sarah Cannon Cancer Network connects patients across the U.S. and U.K. to expert oncology services, including 14 blood cancer treatment programs that make up the Sarah Cannon Transplant and Cellular Therapy Network. Each year, more than 1,000 acute leukemia patients receive treatment through this network.
Looking for treatment for yourself or someone you love? The Sarah Cannon Transplant and Cellular Therapy Program at HCA Florida North Florida Hospital is accepting new patients today.
Proceed to the video attached to the post.
Other articles featuring Navneet Majhail on OncoDaily.